Dr. Kensei Tsuzaka, M.D., Ph.D. Appointed as Chief Advisor at TOKYO RELIFE CLINIC

TOKYO RELIFE CLINIC

Dr. Kensei Tsuzaka, M.D., Ph.D. Appointed as Chief Regenerative Medicine Advisor at Tokyo Relife Clinic — Strengthening Regenerative Medicine Framework Through Integration of Internal Medicine and Immunology Expertise —

Tokyo Relife (Location: Ginza, Chuo-ku, Tokyo; CEO: Yoshiaki Furuyama) is pleased to announce the appointment of Dr. Kensei Tsuzaka, M.D., Ph.D., as the Chief Advisor of Regenerative Medicine at Tokyo Relife Clinic, effective April 1, 2026. This appointment aims to further advance the field of regenerative medicine and enhance the comprehensive medical care system at our clinic.

1.Significance of the Appointment

After graduating from Keio University School of Medicine, Dr. Tsuzaka earned his Ph.D. in Medicine from the university's graduate school. He has extensive international research experience, having engaged in basic medical research at the Oklahoma Medical Research Foundation in the United States. Upon returning to Japan, he built a distinguished career spanning clinical practice, research, and education in the fields of internal medicine and rheumatology, holding prominent positions such as attending physician at Keio University Hospital, Lecturer at Saitama Medical University, and Associate Professor at Tokyo Dental College.

His specialized knowledge in autoimmune diseases, inflammation control, and the integrated treatment of systemic diseases is crucial for the clinical application of regenerative medicine. We believe his expertise will play a core role in the practice of "Longevity Medicine," which our organization is actively promoting.

Through this appointment, Tokyo Relife Clinic aims to establish a more advanced and comprehensive healthcare delivery system by integrating our cutting-edge regenerative medicine technologies—including stem cell therapy, immune cell therapy, and exosome-related treatments—with Dr. Tsuzaka's profound expertise in internal medicine and immunology.

2. Profile (Excerpt)

Chief Advisor of Regenerative Medicine, Tokyo Relife Clinic Kensei Tsuzaka, M.D., Ph.D.

Career History

1988: Graduated from Keio University School of Medicine

1993: Researcher, Oklahoma Medical Research Foundation (USA)

1996: Attending Physician, Keio University Hospital

2000: Lecturer, Saitama Medical University

2009: Completed Graduate Studies at Keio University, obtained Ph.D. in Medicine

2009: Associate Professor, Tokyo Dental College

2026: Chief Advisor of Regenerative Medicine, Tokyo Relife Clinic

Qualifications:

• Doctor of Medicine (Ph.D.)
• Board-Certified Specialist in Internal Medicine, Japanese Society of Internal Medicine
• Board-Certified Rheumatologist, Japan College of Rheumatology

Professional Memberships:

• Japanese Society of Internal Medicine
• Japan College of Rheumatology
• American College of Rheumatology (ACR) Member

3. Comment from Chief Advisor Kensei Tsuzaka

It is a great honor to join Tokyo Relife Clinic as the Chief Advisor of Regenerative Medicine. Throughout my career, I have been involved in clinical practice, research, and education within the field of internal medicine, with a primary focus on autoimmune diseases and inflammation control. In recent years, the advancements in regenerative medicine have begun to open up new possibilities for conditions that have long been challenging to address with conventional treatments.

Moving forward, I will leverage my extensive background in immunology and internal medicine, integrating these disciplines with regenerative medicine to deliver comprehensive and highly personalized care. Above all, I am committed to ensuring that safety and efficacy based on scientific evidence remain our highest priority, so that we may provide medical care of genuine value to our patients."

About General Incorporated Association Tokyo Relife

Tokyo Relife Clinic, operated by General Incorporated Association Tokyo Relife, serves as a core medical institution dedicated to translating advanced research outcomes into clinical applications.

The clinic features an on-site Cell Processing Center (CPC) engineered to stringent safety standards. We deliver medical care that strictly prioritizes quality, safety, and traceability across our core offerings, including stem cell therapy, NK cell therapy, fibroblast therapy, and exosome-related treatments. Furthermore, by integrating highly personalized treatment plans with an exceptionally private environment, the clinic realizes advanced longevity medicine that elevates the overall quality of the patient experience.

End

【Contact for Inquiries】

 *Please select “Other” when submitting your inquiry.